The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

Oura and Dexcom inked a deal to have the Oura Ring app show blood sugar readings from a Dexcom sensor like the Stelo.

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, founded in Finland in 2013, makes a smart ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...